Amerigen, Chinese company partner on generics; India wants Sun, Ranbaxy details; CPhI to chat about pharma's future;

> Strides Arcolab has gotten FDA approval to market in the U.S. buspirone hydrochloride tablets for anxiety disorders. Report

> China's Ningbo Menovo Pharmaceutical will be responsible for manufacturing active pharmaceutical ingredients (API) and finished products as part of a deal with U.S. generic drugmaker Amerigen Pharmaceuticals to make generics for the U.S. market. Story

> The Competition Commission of India (CCI) has given Ranbaxy Laboratories and Sun Pharmaceutical 10 days to present details about their proposed $4 billion merger. Story

> Catalent ($CTLT) will work with Australian biomarker research company Minomic International on an antibody drug conjugate (ADC) for prostate cancer therapy. Report

And Finally... CPhI Worldwide will host a Tweet chat at #CPhIChat to debate the future of pharma during the conference in October. Announcement